Using a new decision-making approach for managing blood sugar in type 2 diabetes
Research on the Effectiveness of Using Decision Cycle for Person-Centered Glycemic Management on Self-Care Behaviors in Outpatients With Type 2 Diabetes
This study tests a new way of helping people with type 2 diabetes manage their blood sugar to see if it works better than the usual education and support they receive.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 130 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | National Taiwan University Hospital Academic / other |
| Locations | 1 site (Hsinchu) |
| Trial ID | NCT06331338 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of a new decision cycle designed for person-centered glycemic management in patients with type 2 diabetes. Participants will be divided into two groups: one receiving the new decision-making approach and the other receiving traditional diabetes self-management education. The goal is to improve self-care behaviors and reduce glycated hemoglobin levels, ultimately delaying complications associated with diabetes. The study will compare outcomes between the two groups after the intervention period.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older diagnosed with type 2 diabetes and having glycated hemoglobin levels between 7.5% and 9.0%.
Not a fit: Patients with type 1 diabetes or those with glycated hemoglobin levels outside the specified range may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to better blood sugar management and improved quality of life for patients with type 2 diabetes.
How similar studies have performed: Other studies have shown promise with person-centered approaches in diabetes management, suggesting potential for success in this novel application.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients diagnosed with type 2 diabetes by a physician. 2. Age: 18 years or above. 3. Glycated hemoglobin (HbA1c ) test value: 7.5-9.0 % 4. No diabetic oral medications, insulin and glucagon-like peptide-1 were replaced in the outpatient when the case was admitted. 5. No pregnancy during the study period. 6. After the researcher explains the purpose of the research, the research subjects agree to join this researcher. 7. Those who are conscious and able to take care of themselves. 8. There is no diagnostic certificate from the American Psychiatric Association's Diagnostic Manual of Mental Disorders, Fourth Edition (DSM-IV)of all mental illnesses. 9. Those who can communicate in Mandarin and Taiwanese. Exclusion Criteria: 1. Patients diagnosed with type 1 diabetes by a physician. 2. Age: Under 18 years old. 3. Glycated hemoglobin test value: less than 7.5 % and greater than 9.0 % 4. Those who replaced oral diabetes medications, insulin and glucagon-like peptide- 1 at the outpatient at the time of admission. 5. Pregnancy during the study period. 6. Those who are unable to take care of themselves and express themselves.
Where this trial is running
Hsinchu
- National Taiwan University Hospital — Hsinchu, Taiwan (Recruiting)
Study contacts
- Principal investigator: Kang-Chih Fan — National Taiwan University
- Study coordinator: Chia-Hui Tsai
- Email: mtsai0322@gmail.com
- Phone: 886926124093
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.